Impact Biomedical (IBO) Tax Rate (2022)

Impact Biomedical (IBO) posted Tax Rate of 35.82% for Q4 2022, up 127.85% on a QoQ basis from 128.63% in Q3 2022.

Impact Biomedical (IBO) Tax Rate (2022) Analysis & Trends

Impact Biomedical's Tax Rate history runs 1 years deep, the most recent figure standing at 35.82% for Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.34%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.29%
4 NuCana 279.75 Bn 279.75 Bn - -5.41%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 17.68%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 12.51%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 33.09%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Impact Biomedical 47.44 Mn 50.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 35.82%
Dec 31, 2022 35.82%
Dec 31, 2022 35.82%
Sep 30, 2022 -128.63%
Sep 30, 2022 -128.63%
Sep 30, 2022 -128.63%